- Home
- MREO vs AMRN Comparison
MREO vs AMRN Comparison
Compare MREO & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- AMRN
- Stock Information
- Founded
- MREO 2015
- AMRN 1989
- Country
- MREO United Kingdom
- AMRN Ireland
- Employees
- MREO N/A
- AMRN N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MREO Health Care
- AMRN Health Care
- Exchange
- MREO Nasdaq
- AMRN Nasdaq
- Market Cap
- MREO 326.1M
- AMRN 302.0M
- IPO Year
- MREO N/A
- AMRN 1993
- Fundamental
- Price
- MREO $1.97
- AMRN $19.29
- Analyst Decision
- MREO Strong Buy
- AMRN Strong Sell
- Analyst Count
- MREO 5
- AMRN 1
- Target Price
- MREO $7.40
- AMRN $12.00
- AVG Volume (30 Days)
- MREO 1.3M
- AMRN 90.2K
- Earning Date
- MREO 11-11-2025
- AMRN 10-29-2025
- Dividend Yield
- MREO N/A
- AMRN N/A
- EPS Growth
- MREO N/A
- AMRN N/A
- EPS
- MREO N/A
- AMRN N/A
- Revenue
- MREO $500,000.00
- AMRN $219,361,000.00
- Revenue This Year
- MREO N/A
- AMRN N/A
- Revenue Next Year
- MREO $72.16
- AMRN N/A
- P/E Ratio
- MREO N/A
- AMRN N/A
- Revenue Growth
- MREO N/A
- AMRN N/A
- 52 Week Low
- MREO $1.47
- AMRN $7.08
- 52 Week High
- MREO $4.72
- AMRN $20.43
- Technical
- Relative Strength Index (RSI)
- MREO 57.79
- AMRN 84.19
- Support Level
- MREO $1.94
- AMRN $15.24
- Resistance Level
- MREO $2.12
- AMRN $15.74
- Average True Range (ATR)
- MREO 0.11
- AMRN 0.78
- MACD
- MREO 0.02
- AMRN 0.44
- Stochastic Oscillator
- MREO 62.65
- AMRN 79.69
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.